Newer Modalities of Ultrasound Imaging and Treatment of the Prostate

Urologic Clinics of North America

Volumn 33, Issue 3, 2006, Pages 329-337

  Amiel, Gilad E ^a   Slawin, Kevin M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADAVER; CANCER CONTROL; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER SURVIVAL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DOPPLER ECHOGRAPHY; FOLLOW UP; GLEASON SCORE; GRAY SCALE ECHOGRAPHY; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; KIDNEY TUMOR; NON INVASIVE MEASUREMENT; ORGAN SIZE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; STRESS INCONTINENCE; SURVIVAL RATE; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION;

HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; ULTRASONIC THERAPY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33745759465     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2006.04.003     Document Type: Review

References (64)

1. Engelbrecht M.R., et al. Prostate cancer staging using imaging. BJU Int 86 Suppl 1 (2000) 123-134
2. Borley N., et al. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT. Scand J Urol Nephrol 37 5 (2003) 382-386
3. D'Amico A.V., et al. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J Clin Oncol 14 6 (1996) 1770-1777
4. Engelbrecht M.R., et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12 9 (2002) 2294-2302
5. Hendrikx A.J., et al. Ultrasonic determination of prostatic volume: a cadaver study. Urology 34 3 (1989) 123-125
6. Aarnink R.G., et al. Formula-derived prostate volume determination. Eur Urol 29 4 (1996) 399-402
7. Aarnink R.G., et al. Planimetric volumetry of the prostate: how accurate is it?. Physiol Meas 16 3 (1995) 141-150
8. Salo J.O., et al. Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy. J Urol 137 3 (1987) 435-438
9. Bates T.S., et al. A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br J Urol 79 6 (1997) 927-932
10. Presti Jr. J.C., et al. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol 166 1 (1996) 103-108
11. Rifkin M.D., et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 323 10 (1990) 621-626
12. Hardeman S.W., et al. Transrectal ultrasound for staging prior to radical prostatectomy. Urology 34 4 (1989) 175-180
13. Augustin H., et al. Differences in biopsy features between prostate cancers located in the transition and peripheral zone. BJU Int 91 6 (2003) 477-481
14. Shinohara K., Wheeler T.M., and Scardino P.T. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 142 1 (1989) 76-82
15. Terris M.K., McNeal J.E., and Stamey T.A. Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 147 3 Pt 2 (1992) 855-857
16. Okihara K., et al. Kinetic analysis of focal hypoechoic lesion in the prostate treated by castration. Prostate 24 5 (1994) 252-256
17. Watanabe H., and Kojima M. The role of prostatic planimetry using transrectal sonography in prostatic diseases. Semin Surg Oncol 13 6 (1997) 425-430
18. Rifkin M.D., Sudakoff G.S., and Alexander A.A. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 186 2 (1993) 509-513
19. Neumaier C.E., et al. Normal prostate gland: examination with color Doppler US. Radiology 196 2 (1995) 453-457
20. Kelly I.M., Lees W.R., and Rickards D. Prostate cancer and the role of color Doppler US. Radiology 189 1 (1993) 153-156
21. Patel U., and Rickards D. The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correlation. Br J Urol 74 5 (1994) 590-595
22. Newman J.S., Bree R.L., and Rubin J.M. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 195 1 (1995) 86-90
23. Bree R.L. The role of color Doppler and staging biopsies in prostate cancer detection. Urology 49 3A Suppl (1997) 31-34
24. Cornud F., et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 49 5 (1997) 709-715
25. Lavoipierre A.M., et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 171 1 (1998) 205-210
26. Halpern E.J., et al. Prostate: high-frequency Doppler US imaging for cancer detection. Radiology 225 1 (2002) 71-77
27. Rubin J.M., et al. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology 190 3 (1994) 853-856
28. Murphy K.J., and Rubin J.M. Power Doppler: it's a good thing. Semin Ultrasound CT MR 18 1 (1997) 13-21
29. Tsuru N., et al. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy. Int J Urol 9 8 (2002) 427-430
30. Kojima M., et al. Preliminary results of power Doppler imaging in benign prostatic hyperplasia. Ultrasound Med Biol 23 9 (1997) 1305-1309
31. Kojima M., et al. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. Eur Urol 37 4 (2000) 436-442
32. Leventis A.K., et al. Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 46 4 (2001) 281-288
33. Tsuru N., et al. Resistance index in benign prostatic hyperplasia using power Doppler imaging and clinical outcomes after transurethral vaporization of the prostate. Int J Urol 12 3 (2005) 264-269
34. Siegal J., and Brawer M.K. Significance of neovascularity in human prostate carcinoma. In: Foster C., and Bostwick D.G. (Eds). Pathology of the prostate: major problems in pathology Vol. 34 (1998), Saunders, Philadelphia p. xvii, 443, [4] of plates
35. Brawer M.K., et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73 3 (1994) 678-687
36. Gasparini G., and Harris A. Prognostic significance of tumor vascularity. In: Teicher B.A. (Ed). Antiangiogenic agents in cancer therapy (1999), Humana Press, Totowa, NJ p. xi, 450
37. Evans S.M., et al. Use of power Doppler ultrasound-guided biopsies to locate regions of tumour hypoxia. Br J Cancer 76 10 (1997) 1308-1314
38. Potdevin T.C., et al. Doppler quantitative measures by region to discriminate prostate cancer. Ultrasound Med Biol 27 10 (2001) 1305-1310
39. Hall M.C., et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 44 6 (1994) 869-875
40. Gee M.S., et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 61 7 (2001) 2974-2982
41. Cornud F., et al. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol 175 4 (2000) 1161-1168
42. Halpern E.J., et al. High-frequency Doppler US of the prostate: effect of patient position. Radiology 222 3 (2002) 634-639
43. Okihara K., Miki T., and Joseph Babaian R. Clinical efficacy of prostate cancer detection using power doppler imaging in American and Japanese men. J Clin Ultrasound 30 4 (2002) 213-221
44. Arger P.H., et al. Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity. J Ultrasound Med 23 5 (2004) 623-630
45. Hsing A.W., Tsao L., and Devesa S.S. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85 1 (2000) 60-67
46. Ellis W.J., et al. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 152 5 Pt 1 (1994) 1520-1525
47. Carter H.B., et al. Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol 142 4 (1989) 1008-1010
48. Hamper U.M., et al. Three-dimensional US of the prostate: early experience. Radiology 212 3 (1999) 719-723
49. Garg S., et al. Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study. J Urol 162 4 (1999) 1318-1321
50. Strasser H., et al. Three-dimensional transrectal ultrasound in staging of localised prostate cancer. J Urol 169 Supp 4 (2003) 299 [A.]
51. Sedelaar J.P., et al. Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology 57 5 (2001) 914-920
52. Chomas J.E., et al. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 48 1 (2001) 232-248
53. Dayton P., et al. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 46 (1999) 220-232
54. Kamiyama N., et al. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol 25 3 (1999) 411-420
55. Tiemann K., et al. Stimulated acoustic emission: pseudo-Doppler shifts seen during the destruction of nonmoving microbubbles. Ultrasound Med Biol 26 7 (2000) 1161-1167
56. Halpern E.J., Rosenberg M., and Gomella L.G. Prostate cancer: contrast-enhanced US for detection. Radiology 219 1 (2001) 219-225
57. Bogers H.A., Sedelaar J.P.M., Beerlage H.P., et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54 (1999) 97-104
58. Frauscher F., et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167 4 (2002) 1648-1652
59. Goossen T., et al. The value of dynamic contrast enhanced power Doppler ultrasound in the localization of prostate carcinoma. Eur Urol 1 Supp 1 (2002) 91
60. Halpern E.J., et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 104 11 (2005) 2373-2383
61. Pepe P., et al. Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer?. Prostate Cancer Prostatic Dis 6 2 (2003) 159-162
62. Madersbacher S., and Marberger M. High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J Endourol 17 8 (2003) 667-672
63. Colombel M., and Gelet A. Principles and results of high-intensity focused ultrasound for localized prostate cancer. Prostate Cancer Prostatic Dis 7 4 (2004) 289-294
64. Blana A., et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63 2 (2004) 297-300